SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/25/20 Perkinelmer Inc 8-K:7 3/25/20 11:182K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 28K 6: R1 Document and Entity Information HTML 54K 9: XML IDEA XML File -- Filing Summary XML 12K 11: XML XBRL Instance -- d908177d8k_htm XML 20K 10: EXCEL IDEA Workbook of Financial Reports XLSX 6K 3: EX-101.DEF XBRL Definitions -- pki-20200325_def XML 41K 4: EX-101.LAB XBRL Labels -- pki-20200325_lab XML 67K 5: EX-101.PRE XBRL Presentations -- pki-20200325_pre XML 42K 2: EX-101.SCH XBRL Schema -- pki-20200325 XSD 17K 7: JSON XBRL Instance as JSON Data -- MetaLinks 14± 22K 8: ZIP XBRL Zipped Folder -- 0001193125-20-084807-xbrl Zip 11K
8-K |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM i 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): i March 25, 2020
PerkinElmer, Inc.
(Exact Name of Registrant as Specified in its Charter)
i Massachusetts |
i 04-2052042 | |||
(State or Other Jurisdiction of Incorporation or Organization) |
(Commission File Number) |
(IRS Employer Identification No.) |
i 940 Winter Street, i Waltham, i Massachusetts |
i 02451 | |
(Address of Principal Executive Offices) |
(Zip Code) |
Registrant’s telephone number, including area code: i (781) i 663-6900
Not applicable.
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
i ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
i ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
i ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
i ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
i Common stock, $1 par value per share |
i PKI |
i The New York Stock Exchange | ||
i 1.875% Notes due 2026 |
i PKI 21A |
i The New York Stock Exchange | ||
i 0.600% Notes due 2021 |
i PKI 21B |
i The New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 | Regulation FD Disclosure. |
In response to anticipated investor questions regarding the press release issued by PerkinElmer, Inc. (the “Company”) on March 24, 2020 announcing the U.S. Food and Drug Administration’s Emergency Use Authorization (EUA) approval of the Company’s new Coronavirus RT-PCR test, the Company expects to provide information that to address growing supply constraints worldwide, it has expanded the production capacity of its extraction and RT-PCR tests at its global facilities and has the capability to ship millions of these solutions to its customers.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PERKINELMER, INC. | ||||||
Date: March 25, 2020 |
By: |
/s/ Joel S. Goldberg | ||||
Senior Vice President, Administration, General Counsel and Secretary |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 3/25/20 | None on these Dates | ||
3/24/20 | ||||
List all Filings |